The genetic variants of the TGF-β1 gene have been implicated in the susceptibility of a large range of carcinoma, including lung cancer [18], oropharyngeal cancer [19], prostate cancer [20] and breast cancer [21, 22]. The gene discussed is TGFB1; the disease is breast cancer.